Banish Solutions
About Banish Solutions
Banish, by Sean Moore, has recently completed market testing of a new treatment for the common cold sore virus. The unique blend of active ingredients and excipients has resulted in a strong value proposition whereby 93% of trial users claimed Banish heals cold sore outbreaks faster than any other product they have used in the past. Banish is about to undergo evaluation from the Therapeutic Goods Administration in order to fully commercialise.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Non-Equity Assistance (Oct 2017)
- Website: banishmycoldsore.com
- Phone: [email protected]
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/banish-solutions-1907841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.